On January 1, 2006, a new federal government program under Medicare began offering prescription drug coverage for the first time to everyone who has Medicare Part A and/or Part B. This coverage, known as Part D, is provided through private companies whose plans are approved by Medicare.
New Jersey's Department of Human Services has created this Web site to help Pharmaceutical Assistance to the Aged and Disabled program (PAAD) and Senior Gold Prescription Discount program (Senior Gold) beneficiaries and caregivers learn more about Medicare Part D and what it means for them.
New Jersey's PAAD program continues to provide state-funded prescription assistance to nearly 143,000 New Jersey residents. Learn more.
New Jersey's Senior Gold program continues to provide state-funded prescription assistance to nearly 23,000 New Jersey residents. Learn more.
Your friends and loved ones who are currently PAAD and Senior Gold beneficiaries continue to be provided with state-funded prescription assistance. You can get information here to help PAAD and Senior Gold beneficiaries make decisions about Medicare prescription drug coverage and to learn what they need to do to use their state prescription benefits.
Bringing a new pharmaceutical to market is a time-consuming, expensive, and scientifically rigorous process. Similar to medicines under review for use in humans, companies must demonstrate that the pharmaceutical is safe and effective in animals. A 2015 study of the US domestic market by HealthforAnimals found that on average, when developing a new active ingredient, it takes years and $ million to bring a new companion animal pharmaceutical to market and years and $ million for a new pharmaceutical product for livestock. These are averages and costs of over $62 million. Overall development costs have increased by more than 50% since 2011.
Pharmaceutica-2015 offers its heartfelt appreciation to organizations such as Dubai Pharmacy College , Spanish Association of Pharmaceutical Industry and esteemed organizations, obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums and took privilege to felicitate the Organizing Committee Members, Editorial Board Members and Media Partners who supported this event.